These materials are available for nonprofit educational use. This repository is allowed by copyright disclaimer under title 17, Appendix E, section 107 of the United States Copyright Act. Under this statute, allowance is made for “fair use” for purposes such as criticism, comment, news reporting, teaching, scholarship, and research. As defined, fair use specifically applies to this repository.
Fibrocytes are present locally and in circulation in a number of fibrotic diseases, including Dupuytren disease.
- Bellini A, Mattoli S. The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses. Lab Invest. 2007;87(9):858–70. (PDF)
- Bucala R, Spiegel L a, Chesney J, Hogan M, Cerami a. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med. 1994;1(1):71–81. (PDF)
- Grieb G, Bucala R. Fibrocytes in Fibrotic Diseases and Wound Healing. Adv wound care. 2012;1(1):36–40. (PDF)
- Herzog EL, Bucala R. Fibrocytes in health and disease. Exp Hematol. BioMed Central Ltd; 2011;38(7):548–56. (PDF)
- Iqbal SA, Hayton MJ, Watson JS, Szczypa P, Bayat A. First identification of resident and circulating fibrocytes in Dupuytren’s disease shown to be inhibited by serum amyloid P and Xiapex. PLoS One. 2014;9(6):e99967. (PDF)
- Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol. 2008;214(2):199–210. (PDF)